Tsarin Turai don 3′-Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9

Quality First, kuma Client koli ne mu jagora don sadar da sosai mafi kyau taimako ga mu siyayya.These days, we have been kokarin mu mafi girma ya zama daga cikin manufa fitarwa a cikin filin mu cika mabukaci karin so bukatar Turai style for 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, Ta hanyar ƙarin shekaru 8 na ƙananan kasuwanci, yanzu mun sami ƙwarewa mai arha da fasahar ci gaba yayin kera samfuranmu.
Ingancin Farko, kuma Babban Abokin Ciniki shine jagorarmu don isar da mafi kyawun taimako ga masu siyayyar mu. A kwanakin nan, mun kasance muna ƙoƙari mafi girman mu don kasancewa cikin masu fitar da kayayyaki masu kyau a cikin filinmu don cika masu siye da ƙarin buƙatu.China 77-92-9 da CAS 77-92-9, Dangane da layin samar da mu ta atomatik, tashar siyar da kayan siye da sauri an gina su a cikin babban yankin kasar Sin don saduwa da buƙatun abokin ciniki mafi girma a cikin 'yan shekarun nan.Mun kasance muna fatan yin haɗin gwiwa tare da ƙarin abokan ciniki a duk duniya don ci gaba tare da fa'ida!Tsayawa gaskiya, sabbin abubuwa da inganci, muna sa rai da gaske cewa za mu iya zama abokan kasuwanci don ƙirƙirar kyakkyawar makoma!

Ana amfani da 2'-hydroxy-3'-nitro-3-biphenylcarboxylic acid azaman matsakaici na Eltrombopag.
Eltrombopag, wanda GlaxoSmithKline (GSK) ya haɓaka a Burtaniya kuma daga baya aka haɓaka tare da Novartis a Switzerland, shine farkon kuma kawai wanda aka amince da ƙananan ƙwayoyin cuta marasa peptide TPO agonist a duniya.An amince da Eltrombopag ta FDA ta Amurka a cikin 2008 don maganin cututtukan thrombocytopenic purpura (ITP), kuma a cikin 2014 don maganin anemia mai tsanani (AA).Hakanan shine magani na farko da FDA ta Amurka ta amince don maganin AA a cikin shekaru 30 na baya-bayan nan.
A cikin Disamba 2012, FDA ta Amurka ta amince da Eltrombopag don maganin thrombocytopenia a cikin marasa lafiya tare da ciwon hanta na kullum C (CHC), don haka marasa lafiya na hepatitis C tare da rashin jin dadi saboda ƙananan platelet zasu iya farawa da kuma kula da interferon bisa daidaitattun maganin cututtuka na hanta.A ranar 3 ga Fabrairu, 2014, GlaxoSmithKline ya sanar da cewa FDA ta ba da nasarar cancantar maganin miyagun ƙwayoyi na Eltrombopag don maganin hemopenia a cikin marasa lafiya tare da anemia mai tsanani na sinadarai (SAA) waɗanda ba su da cikakkiyar amsa ga immunotherapy.A ranar 24 ga Agusta, 2015, FDA ta Amurka ta amince da Eltrombopag don maganin thrombocytopenia a cikin manya da yara masu shekaru 1 da haihuwa tare da thrombocytopenia na rigakafi na yau da kullum (ITP) waɗanda basu da isasshen amsa ga corticosteroids, immunoglobulins ko splenectomy.A ranar 4 ga Janairu, 2018, an amince da Eltrombopag da za a jera shi a kasar Sin don maganin thrombocytopenia na rigakafi na farko (ITP).

Quality First, kuma Client koli ne mu jagora don sadar da sosai mafi kyau taimako ga mu siyayya.These days, we have been kokarin mu mafi girma ya zama daga cikin manufa fitarwa a cikin filin mu cika mabukaci karin so bukatar Turai style for 3′- Hydroxy-3-Biphenylcarboxylic Acid Citric Acid 77-92-9, Ta hanyar ƙarin shekaru 8 na ƙananan kasuwanci, yanzu mun sami ƙwarewa mai arha da fasahar ci gaba yayin kera samfuranmu.
Turai salonChina 77-92-9 da CAS 77-92-9, Dangane da layin samar da mu ta atomatik, tashar siyar da kayan siye da sauri an gina su a cikin babban yankin kasar Sin don saduwa da buƙatun abokin ciniki mafi girma a cikin 'yan shekarun nan.Mun kasance muna fatan yin haɗin gwiwa tare da ƙarin abokan ciniki a duk duniya don ci gaba tare da fa'ida!Tsayawa gaskiya, sabbin abubuwa da inganci, muna sa rai da gaske cewa za mu iya zama abokan kasuwanci don ƙirƙirar kyakkyawar makoma!